Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

APPLICATION OF A GENERIC PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL TO THE ESTIMATION OF XENOBIOTIC LEVELS IN RAT PLASMA

F. A. Brightman, D. E. Leahy, G. E. Searle and S. Thomas
Drug Metabolism and Disposition January 2006, 34 (1) 84-93; DOI: https://doi.org/10.1124/dmd.105.004804
F. A. Brightman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. E. Leahy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. E. Searle
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Thomas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 34 no. 1 84-93
DOI 
https://doi.org/10.1124/dmd.105.004804
PubMed 
16221757

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received March 23, 2005
  • Accepted October 11, 2005
  • Published online December 20, 2005.

Article Versions

  • Earlier version (October 12, 2005 - 07:56).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. F. A. Brightman,
  2. D. E. Leahy,
  3. G. E. Searle and
  4. S. Thomas
  1. Cyprotex Discovery Ltd., Macclesfield, Cheshire, United Kingdom
  1. Address correspondence to:
    Dr. David E. Leahy, Cyprotex Discovery Ltd., 13–15 Beech Lane, Macclesfield, Cheshire, United Kingdom, SK10 2DR. E-mail: d.leahy{at}cyprotex.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 20170146
Sep 201702310
Oct 201703010
Nov 20171254
Dec 20170161
Jan 20180104
Feb 20180184
Mar 20182186
Apr 201811913
May 201801512
Jun 201802312
Jul 201801116
Aug 20180104
Sep 20180155
Oct 20181108
Nov 20182169
Dec 20181267
Jan 2019512
Feb 20191502
Mar 2019513
Apr 20191226
May 20191012
Jun 20191212
Jul 20191407
Aug 20191513
Oct 20191145
Nov 20192456
Dec 20191645
Jan 20201903
Feb 2020900
Mar 20201026
May 20201967
Jun 20202307
Jul 20203526
Aug 202023417
Sep 20202401
Oct 20203617
Nov 20202279
Dec 20201534
Jan 20212376
Feb 2021934
Mar 20214642
Apr 20211821
May 20211352
Jun 20211543
Jul 202114611
Aug 2021261612
Sep 20212552
Oct 20211942
Nov 20212132
Dec 20213425
Jan 20222511
Feb 20221412
Mar 2022710
Apr 20223033
May 20222538
Jun 20224546
Jul 20222044
Aug 20225149
Sep 20223387
Oct 20223854
Nov 20222939
Dec 20221711
Jan 20233634
Feb 202317610
Mar 20232210

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 34 (1)
Drug Metabolism and Disposition
Vol. 34, Issue 1
1 Jan 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
APPLICATION OF A GENERIC PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL TO THE ESTIMATION OF XENOBIOTIC LEVELS IN RAT PLASMA
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

APPLICATION OF A GENERIC PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL TO THE ESTIMATION OF XENOBIOTIC LEVELS IN RAT PLASMA

F. A. Brightman, D. E. Leahy, G. E. Searle and S. Thomas
Drug Metabolism and Disposition January 1, 2006, 34 (1) 84-93; DOI: https://doi.org/10.1124/dmd.105.004804

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

APPLICATION OF A GENERIC PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL TO THE ESTIMATION OF XENOBIOTIC LEVELS IN RAT PLASMA

F. A. Brightman, D. E. Leahy, G. E. Searle and S. Thomas
Drug Metabolism and Disposition January 1, 2006, 34 (1) 84-93; DOI: https://doi.org/10.1124/dmd.105.004804
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • AKRs and GUSs in Testosterone Disposition
  • Olanzapine Glucuronidation in Humanized Mice
  • rs2242480 Regulates the Expression of CYP3A4 and CYP3A5
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics